@article{1c127a19bcf241f78a5a5a086c38a4dd,
title = "Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis",
keywords = "Adenine, Electronic Health Records, Heart, Humans, Piperidines/adverse effects, United States/epidemiology",
author = "Gent, {David G.} and Rivera-Caravaca, {Jos{\'e} M.} and Rebecca Dobson and Wright, {David J.} and Lip, {Gregory Y.H.} and Nicklas Vinter and Francisco Mar{\'i}n and Paula Underhill",
note = "Funding Information: We acknowledge the participating healthcare organisations who allowed TriNetX Inc. access to their electronic medical records. We cannot reveal the identity of these organisations due to data privacy restrictions. Further collaborators of the Liverpool Centre for Cardiovascular Science not listed on the author by-line are: Nicklas Vinter, Francisco Mar{\'i}n, and Paula Underhill. Funding Information: Dr. Rivera-Caravaca has received a grant from Sociedad Espa..ola de Trombosis y Haemostasis (grant for short international training stays 2020), and the First Contact Initiative Grant 2020 from the European Society of Cardiology Council on Basic Cardiovascular Science. Prof. Wright has received consultancy and speaker fees from Boston Scientific and Medtronic. Prof Lip has received consultancy and speaker fees from Bayer, Bayer/Janssen, Bristol Myers Squibb/Pfizer, Biotronik, Medtronic. Boehringer Ingelheim, Microlife, Roche, and Daiichi-Sankyo outside the submitted work. All other authors have no relationships relevant to the content of this paper to disclose. ",
year = "2023",
month = feb,
doi = "10.1016/j.ejim.2022.09.016",
language = "English",
volume = "108",
pages = "117--119",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier",
}